vilanterol
Showing 1 - 25 of 153
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate (low dose), Vilanterol and Fluticasone Furoate
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate (low dose)
- +2 more
-
Copenhagen, DK, DenmarkAugust Krogh Building
Sep 27, 2023
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Oct 4, 2023
Using US Medical and Pharmacy Claim Records to Compare Resource
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
Eden Prairie, MinnesotaOptum
Mar 11, 2022
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- (no location specified)
Sep 7, 2022
COPD Trial in Mexico City (Fluticasone Furoate/Vilanterol 100/25 mcgs, Umeclidinium/Vilanterol 62.5/25 mcgs)
Completed
- COPD
- Fluticasone Furoate/Vilanterol 100/25 mcgs
- Umeclidinium/Vilanterol 62.5/25 mcgs
-
Mexico City, Tlalpan, MexicoNational Institute of Respiratory Diseases 'Ismael Cosío Villega
Apr 18, 2022
Replication of the IMPACT COPD Trial in Healthcare Claims Data
Completed
- COPD
- Fluticasone Furoate-Vilanterol Trifenatate
- Furoate-umeclidinium-vilanterol
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 20, 2021
Pharmacokinetics Trial in Copenhagen (Fluticasone Furoate/ Vilanterol Trifenatate)
Completed
- Pharmacokinetics
- Fluticasone Furoate/ Vilanterol Trifenatate
-
Copenhagen, DenmarkRespiratory research unit, Bispebjerg University Hospital
Jan 26, 2021
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- ELLIPTA
- (no location specified)
Aug 15, 2022
Copd, Heart Failure Trial (Umeclidinium/vilanterol, Placebo)
Not yet recruiting
- Copd
- Heart Failure
- Umeclidinium/vilanterol
- Placebo
- (no location specified)
Feb 17, 2021
COPD Trial in Keswick (Anoro Ellipta, Arnuity Ellipta)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Anoro Ellipta
- Arnuity Ellipta
-
Keswick, VirginiaRoselove NUNOO-ASARE
May 3, 2022
COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- BDP/FF/GB
- FlF/VI + Tiotropium
-
Godollo, HungaryErzsebet Gondozohaz
Oct 28, 2021
Asthma in Children Trial in Haifa (Fluticasone furoate (FF)/Vilanterol (VI), Salbutamol)
Completed
- Asthma in Children
- Fluticasone furoate (FF)/Vilanterol (VI)
- Salbutamol
-
Haifa, IsraelRambam Medical Center
Feb 10, 2021
COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol
Withdrawn
- COPD
- Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
- Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
- (no location specified)
Jan 19, 2022
Based on Medical Records That Looks at Duration of Use of Two
Completed
- Pulmonary Disease, Chronic Obstructive
- Olodaterol/Tiotropium Bromide
- Umeclidinium/ Vilanterol
-
New York, New YorkAetion Inc.
Nov 12, 2021
US Based on Pharmacy and Medical Claims That Compares How Well
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
White Plains, New YorkeMax health
Jan 11, 2022
COPD, Non Small Cell Lung Cancer Trial in Seoul (Vilanterol and Umeclidinium Bromide, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Non Small Cell Lung Cancer
- Vilanterol and Umeclidinium Bromide
- Placebo
-
Seoul, Korea, Republic ofSamsung Medical Center
Apr 1, 2021
COPD Trial in Germany, United Kingdom (AZD8871, Anoro® Ellipta®)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD8871
- Anoro® Ellipta®
-
Berlin, Germany
- +4 more
Nov 24, 2020
Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting
Withdrawn
- Pulmonary Disease, Chronic Obstructive
- Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
- Fluticasone furoate/umeclidinium/vilanterol
-
Waterbury, Connecticut
- +2 more
Apr 21, 2020
COPD Trial in United Kingdom (Tiotropium & olodaterol, fluticasone furoate & vilanterol)
Completed
- Chronic Obstructive Pulmonary Disease
- Tiotropium & olodaterol
- fluticasone furoate & vilanterol
-
Dundee, United Kingdom
- +3 more
Jul 16, 2020
Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +7 more
-
Andalusia, Alabama
- +71 more
Jul 13, 2021
Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)
Completed
- Asthma
- FF/VI via ELLIPTA DPI
- FF via ELLIPTA DPI
-
Hoover, Alabama
- +183 more
Sep 12, 2022
Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)
Not yet recruiting
- Copd
- TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
-
Dallas, TexasBaylor Scott & White Health Research Institute
Mar 22, 2022